PROCEPT BioRobotics (PRCT) Cash from Operations (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Cash from Operations data on file, last reported at 38127000.0 in Q1 2026.

• On a quarterly basis, Cash from Operations fell 124.54% year-over-year to 38127000.0 in Q1 2026; TTM through Mar 2026 was 70132000.0, a 16.42% increase from a year earlier, with the FY2025 full-year figure at 48985000.0, up 50.63% from the prior year.
• Cash from Operations for Q1 2026 stood at 38127000.0, down from 10327000.0 in the prior quarter.
• Over the last five years, Cash from Operations for PRCT reached as high as 6635000.0 in Q3 2025 and fell as low as 38127000.0 in Q1 2026.
• Historically, Cash from Operations has averaged 22041764.71 across 5 years, with a median of 18943000.0 in 2023.
• Across the five-year window, Cash from Operations jumped 68.12% in 2025 and tumbled 124.54% in 2026, its largest moves.
• Year by year, Cash from Operations stood at 25174000.0 in 2022, then grew by 1.51% to 24793000.0 in 2023, then plunged by 30.65% to 32391000.0 in 2024, then soared by 68.12% to 10327000.0 in 2025, then slumped by 269.2% to 38127000.0 in 2026.
• Per Business Quant data, the three most recent Cash from Operations figures were 38127000.0 in Q1 2026, 10327000.0 in Q4 2025, and 6635000.0 in Q3 2025.